secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001501697-25-000032
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals raises ~$145.6M in public offering of common stock and warrants
--------------------------------------------------------------------------------

- Offering of 45.86M shares at $2.90/share and pre-funded warrants for 700K shares at $2.899/share.
- Underwriters' option for additional 6.984M shares exercised in full.
- Net proceeds expected ~$145.6M after discounts and expenses; closing October 27, 2025.
- Offered under effective shelf registration (333-273961); Leerink, Stifel, Guggenheim as representatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000150169725000032/0001501697-25-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000150169725000032/xfor-20251023.htm
  HTML page:      https://secwatch.observer/filing/0001501697-25-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer